Optical fiber-based setup for in vivo measurement of the delayed fluorescence lifetime of oxygen sensors

Journal of Biomedical Optics

Volumn 16, Issue 3, 2011, Pages

  Piffaretti, Filippo ^a   Santhakumar, Kanappan ^a   Forte, Eddy ^a   Van Den Bergh, Hubert E ^a   Wagnierès, Georges A ^a  

^a EPFL   (Switzerland)

Author keywords

Delayed fluorescence; In vivo; Lifetime; Luminescence; PpIX; Tissular oxygen

Indexed keywords

DELAYED FLUORESCENCE; IN-VIVO; LIFETIME; PPIX; TISSULAR OXYGEN;

DETECTORS; DYE LASERS; ENCLOSURES; LASER EXCITATION; LIGHT; MIRRORS; OPTICAL FIBERS; OXYGEN; PHOTODYNAMIC THERAPY; PUMPING (LASER); QUARTZ; TEXTILE FIBERS; TISSUE;

FLUORESCENCE;

FLUORESCENT DYE; GLASS FIBER; MESOPORPHYRIN; METALLOPORPHYRIN; OXYGEN; PALLADIUM MESO TETRA(4 CARBOXYPHENYL)PORPHINE; PALLADIUM-MESO-TETRA(4-CARBOXYPHENYL)PORPHINE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ANIMAL; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; FLUORESCENCE; HUMAN; INSTRUMENTATION; LIGHT RELATED PHENOMENA; METABOLISM; METHODOLOGY; OPTICAL INSTRUMENTATION; PHOTOCHEMOTHERAPY; SPECTROFLUOROMETRY; STATISTICS; VALIDATION STUDY;

ANIMALS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MESOPORPHYRINS; METALLOPORPHYRINS; OPTICAL DEVICES; OPTICAL FIBERS; OPTICAL PHENOMENA; OXYGEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SPECTROMETRY, FLUORESCENCE;

EID: 79961191381     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3558846     Document Type: Article

References (76)

1. Y. Monnier, P. Pasche, P. Monnier, and S. Andrejevic-Blant, "Second primary squamous cell carcinoma arising in cutaneous flap reconstructions of two head and neck cancer patients," Eur Arch Otorhinolaryngol 265(7), 831-835 (2008).
2. P. Grosjean, G. Wagnieres, C. Fontolliet, H. van den Bergh, and P. Monnier, "Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II," Br. J. Cancer 77(11), 1989-1995 (1998).
3. M. Triesscheijn, P. Baas, J. H. M. Schellens, and F. A. Stewart, "Photodynamic therapy in oncology," Oncologist 11(9), 1034-1044 (2006).
4. A. P. Castano, T. N. Demidova, and M. R. Hamblin, "Mechanisms in photodynamic therapy: Part one photosensitizers, photochemistry and cellular localization," Photodiagnosis and Photodynamic Therapy 1(4), 279-293 (2004).
5. R. Bonnett, "Photodynamic therapy in historical perspective," Reviews in Contemporary Pharmacotherapy 10, 1-18 (1999).
6. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K. E. Giercksky, and J. M. Nesland, "5-Aminolevulinic acid-based photodynamic therapy. clinical research and future challenges," Cancer 79(12), 2282-2308 (1997).
7. S. Pervaiz and M. Olivo, "Art and science of photodynamic therapy," Clini. Exp. Pharmacol. Physiol. 33, 551-556 (2006).
8. K. Plaetzer, B. Krammer, J. Berlanda, F. Berr, and T. Kiesslich, "Photophysics and photochemistry of photodynamic therapy: fundamental aspects," Lasers Med. Sci. 24(2), 259-268 (2009).
9. B. C. Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetry in photodynamic therapy: a new paradigm," Lasers Med. Sci. 12(3), 182-199 (1997).
10. P. K. Kaiser, "Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand?" Br. J. Ophthalmol. 94(2), 143-145 (2010).
11. G. R. Kürzinger, B. Stender, G. K. Lang, and G. E. Lang, "Photodynamic therapy witverteporfin in occult choroidal neovascularization in age-related macular degeneration," Klin Monbl Augenheilkd 131(5), 541-560 (2010).
12. E. G. Mik, T. Johannes, C. J. Zuurbier, A. Heinen, J. H. P. M. Houben-Weerts, G. M. Balestra, J. Stap, J. F. Beek, and C. Ince, "In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique," Biophys. J. 95(8), 3977-3990 (2008).
13. M. Geissbuehler, T. Spielmann, A. Formey, I. Märki, M. Leutenegger, B. Hinz, K. Johnsson, D. Van De Ville, and T. Lasser, "Triplet imaging of oxygen consumption during the contraction of a single smooth muscle cell (A7r5)," Biophys. J. 98(2), 339-349 (2010).
14. H. Van den Bergh and J.-P. Ballini, "Photodynamic therapy: basic principles and mechanisms," in Lasers in Ophthalmology Surgical and Diagnostic Aspects, pp. 1-23, Kugler, The Hague, The Netherlands (2002).
15. L. Zhao, K. P. Nielsen, A. Juzeniene, P. Juzenas, V. Lani, L.-W. Ma, K. Stamnes, J. J. Stamnes, and J. Moan, "Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-Aminolevulinic acid," J. Environ. Pathol. Toxicol. Oncol. 25(2), 307-320 (2006).
16. J. Moan and P. Juzenas, "Singlet oxygen in photosensitization," J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 29-50 (2006).
17. F. Borle, A. Radu, P. Monnier, H. van den Bergh, and G. Wagnières, "Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects," Photochem. Photobiol. 78(4), 377-383 (2003).
18. S. Piermarocchi, M. Sartore, G. Lo Giudice, G. Monterosso, E. Pilotto, and T. Segato, "Is there any relationship between photodynamic therapy for exudative age-related macular degeneration and choroidal neovascolarization recurrence? A rationale for combined treatments," Eur. J. Ophthalmol. 16(5), 686-694 (2006).
19. S. Szabo, M. Potter, and T. Ho, "Incidence of recurrence of choroidal neovascular membranes at 18 months after photodynamic therapy in patients with age-related macular degeneration," Invest. Ophthalmol. Vis. Sci. 46(5), e-abstract 300 (2005).
20. K. Cengel, E. Glatstein, and S. Hahn, Intraperitoneal Photodynamic Therapy, Vol. 6, Springer, New York (2007).
21. B. C. Wilson and M. S. Patterson, "The physics, biophysics and technology of photodynamic therapy," Phys. Med. Biol. 53(9), R61-R109 (2008).
22. F. Krummenauer, M. Braun, and H. B. Dick, "Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration," Eur. J. Ophthalmol. 15(1), 74-80 (2005).
23. E. Stefánsson, R. Machemer, E. de Juan, B. W. McCuen, and J. Peterson, "Retinal oxygenation and laser treatment in patients with diabetic retinopathy," Am. J. Ophthalmol. 113(1), 36-38 (1992).
24. S. R. Chamot, S. D. Cranstoun, B. L. Petrig, C. J. Pournaras, and C. E. Riva, "Blood pO2 and blood flow at the optic disc," J. Biomed. Opt. 8(1), 63-69 (2003).
25. C. E. Riva, "Noninvasive measurement of oxygen tension in the optic nerve head," Curr. Opin. Ophthalmol. 9(2), 56-60 (1998).
26. N. D. Wangsa-Wirawan and R. A. Linsenmeier, "Retinal oxygen: fundamental and clinical aspects," Arch. Ophthalmol. 121(4), 547-557 (2003).
27. M. Ito, K. Murayama, T. Deguchi, M. Takasu, T. Gil, M. Araie, G. Peyman, and S. Yoneya, "Oxygen saturation levels in the juxta-papillary retina in eyes with glaucoma," Exp. Eye. Res. 86(3), 512-518 (2008).
28. O. Arjamaa and M. Nikinmaa, "Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors," Exp. Eye. Res. 83(3), 473-483 (2006).
29. R. D. Shonat, D. F. Wilson, C. E. Riva, and M. Pawlowski, "Oxygen distribution in the retinal and choroidal vessels of the cat as measured by a new phosphorescence imaging method," Appl. Opt. 31(19), 3711-3718 (1992).
30. S. A. Vinogradov, L. W. Lo, W. T. Jenkins, S. M. Evans, C. Koch, and D. F. Wilson, "Noninvasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors," Biophys. J. 70(4), 1609-1617 (1996).
31. W. L. Rumsey, J. M. Vanderkooi, and D. F. Wilson, "Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue," Science 241(4873), 1649-1651 (1988).
32. 2 of the pig retina as measured with phosphorescence imaging," Surv. Ophthalmol. 42(Suppl 1), S118-S126 (1997).
33. M. P. Tsvirko, K. N. Solovev, A. T. Gradyzshko, and S. S. Dvornikov, "Phosphorescence of porphyrin free base and their complexes with light metals," Opt. Spektrosk. 38, 705-713 (1975).
34. A. Molnàr, R. Dedic, A. Svoboda, and J. Hála, "Singlet oxygen production by lipophilic photosensitizers in liposomes studied by time and spectral resolved phosphorescence," J. Mol. Struct. 834-836, 488-491 (2007).
35. H. Sterenborg, J. de Wolf, M. Koning, B. Kruijt, A. Van Den Heuvel, and D. J. Robinson, "Phosphorescence-fluorescence ratio imaging for monitoring the oxygen status during photodynamic therapy," Opt. Express 12(9), 1873-1878 (2004).
36. A. Molnar, R. Dedic, A. Svoboda, and J. Hala, "Singlet oxygen production by lipophilic photosensitizers in liposomes studied by time and spectral resolved phosphorescence," J. Mol. Struct. 834-836, 488-491 (2007).
37. W. Melhuish, "Nomenclature, symbols, units and their usage in spectrochemical analysis - VI molecular luminescence spectroscopy," Spectrochim. Acta 37(3), 259-272 (1982).
38. C. Ince and E. G. Mik, "Device and Method for Determining the Concentration of a Substance," (2007), European Patent 1,742,038.
39. S. Kuszaj, P. Kaszycki, and Z. Wasylewski, "A fluorescence quenching study on protoporphyrin IX in a model membrane system," Chem. Phys. Lipids 83(2), 153-160 (1996).
40. M. Kress, T. Meier, R. Steiner, F. Dolp, R. Erdmann, U. Ortmann, and A. Rück, "Time-resolved microspectrofluorometry and fluorescence lifetime imaging of photosensitizers using picosecond pulsed diode lasers in laser scanning microscopes," J. Biomed. Opt. 8(1), 26-32 (2003).
41. J. Russell, K. Diamond, T. Collins, H. Tiedje, J. Hayward, and T. Farrell, "Characterization of fluorescence lifetime of photofrin and delta-aminolevulinic acid induced protoporphyrin IX in living cells using single- and two-photon excitation," IEEE J. Sel. Top. in Quantum Electron. 14(1), 158-166 (2008).
42. C. A. Parker, Photoluminescence of Solutions, Elsevier, Amsterdam (1968).
43. A. A. Krasnovsky, "Primary mechanisms of photoactivation of molecular oxygen. History of development and the modern status of research," Biochemistry (Mosc.) 72(10), 1065-1080 (2007).
44. R. Schmidt, "Photosensitized generation of singlet oxygen," Photochem. and Photobiol. 82(5), 1161-1177 (2007).
45. D. W. Marquardt, "An algorithm for least-squares estimation of nonlinear parameters," J. Soc. Ind. Appl. Math. 11(2), 431-441 (1963).
46. J. Moré, "The Levenberg-Marquardt algorithm: Implementation and theory," Numerical Analysis 630, 105-116 (1978).
47. E. G. Mik, C. Donkersloot, N. J. H. Raat, and C. Ince, "Excitation pulse deconvolution in luminescence lifetime analysis for oxygen measurements in vivo," Photochem. Photobiol. 76(1), 12-21 (2002).
48. T. Roth, "Ruthenium(II) diimine complexes for luminescence-based oxygen sensors and Impedance spectroscopy of nitrogen dioxide-sensitive polymeric membranes," Ph.D. thesis, Swiss Federal Institute of Technology, Zurich, Diss. ETH No. 14001 (1972).
49. T. K. Stepinac, S. R. Chamot, E. Rungger-Brändle, P. Ferrez, J.-L. Munoz, H. van den Bergh, C. E. Riva, C. J. Pournaras, and G. A. Wagnières, "Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes," Invest. Ophthalmol. Visual Sci. 46(3), 956-966 (2005).
50. G. E. P. Box, G. M. Jenkins, and G. C. Reinsel, Time Series Analysis. Forecasting and Control. 4th ed., p. 746 John Wiley and Sons, Hoboken, NJ (2008).
51. A. Fassò, "Residual autocorrelation distribution in the validation data set," J. Time Ser. Anal. 21(2), 143-153 (2000).
52. S. V. Eliseeva, M. Ryazanov, F. Gumy, S. I. Troyanov, L. S. Lepnev, J.-C. G. Bünzli, and N. P. Kuzmina, "Dimeric complexes of Lanthanide(III) hexafluoroacetylacetonates with 4-Cyanopyridine N-oxide: synthesis, crystal structure, magnetic and photoluminescent properties," Eur. J. Inorg. Chem. 2006(23), 4809-4820 (2006).
53. A.-S. Chauvin, S. Comby, B. Song, C. D. B. Vandevyver, and J.-C. G. Bünzli, "A versatile ditopic ligand system for sensitizing the luminescence of bimetallic lanthanide bio-imaging probes," Chemistry 14(6), 1726-1739 (2008).
54. S. J. Chantrell, C. McAuliffe, A. R. Munn, and A. W. C. Pratt, "Luminescence from protoporphyrin IX dimethyl ester," J. Chem. Soc. Commun. 470-471 (1975).
55. S. J. Chantrell, "Excited states of protoporphyrin IX dimethyl ester reaction of the triplet with carotenoids," J. Chem. Soc. 76, 417-425 (1980).
56. 2 measured by delayed fluorescence of endogenous protoporphyrin IX," Nat. Methods 3(11), 939-945 (2006).
57. J. M. Vanderkooi, G. Maniara, T. J. Green, and D. F. Wilson, "An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence," J. Biol. Chem. 262(12), 5476-5482 (1987).
58. D. Mauzerall and J. Feitelson, "Reactions of triplet states of a porphyrin measured by delayed fluorescence," J. Phys. Chem. 86(9), 1623-1628 (1982).
59. S. A. Vinogradov and D. F. Wilson, "Metallotetrabenzoporphyrins. New phosphorescent probes for oxygen measurements," J. Chem. Soc., Perkin Trans. 2, 103-111 (1995).
60. S. A. Vinogradov and D. F. Wilson, "Phosphorescence lifetime analysis with a quadratic programming algorithm for determining quencher distributions in heterogeneous systems," Biophys. J. 67(5), 2048-2059 (1994).
61. K. Tsukada, S. Sakai, K. Hase, and H. Minamitani, "Development of catheter-type optical oxygen sensor and applications to bioinstrumentation, " Biosens. Bioelectron. 18(12), 1439-1445 (2003).
62. J. Moan, "The photochemical yield of singlet oxygen from porphyrins in different states of aggregation," Photochem. Photobiol. 4, 445-449 (1984).
63. L. M. Scolaro, M. Castriciano, A. Romeo, S. Patane, E. Cefal, and M. Allegrini, "Aggregation Behavior of Protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation," J. Phys. Chem. B 106(10), 2453-2459 (2002).
64. M. R. Calvo, J. U. Andersen, P. Hvelplund, S. B. Nielsen, U. V. Pedersen, J. Rangama, S. Tomita, and J. S. Forster, "Photophysics of protoporphyrin ions in vacuo: Triplet-state lifetimes and quantum yields," J. Chem. Phys. 120(11), 5067-5072 (2004).
65. J. Lafferty and T. G. Truscott, "Triplet state of protoporphyrin IX," J. Chem. Soc. 1978, 51-52 (1978).
66. C. Perotti, H. Fukuda, G. DiVenosa, A. J. MacRobert, A. Batlle, and A. Casas, "Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies," Br. J. Cancer 90(8), 1660-1665 (2004).
67. A. Casas, H. Fukuda, G. Di Venosa, and A. Batlle, " Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy," Br. J. Cancer 85(2), 279-284 (2001).
68. R. F. Donnelly, P. A. McCarron, and A. D. Woolfson, "Derivatives of 5-aminolevulinic acid for photodynamic therapy," Perspect Medicin Chem. 1, 49-63 (2008).
69. N. Fotinos, M. A. Campo, F. Popowycz, R. Gurny, and N. Lange, "5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives," Photochem. Photobiol. 82(4), 994-1015 (2006).
70. J. C. Kennedy and R. H. Pottier, "Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy," J. Photochem. Photobiol. B 14(4), 275-292 (1992).
71. H. Fukuda, A. Casas, and A. Batlle, "Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy," Int. J. Biochem. Cell Biol. 37(2), 272-276 (2005).
72. A. M. Batlle, "Porphyrins, porphyrias, cancer and photodynamic therapy a model for carcinogenesis," J. Photochem. Photobiol. B 20(1), 5-22 (1993).
73. S. Collaud, A. Juzeniene, J. Moan, and N. Lange, "On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation," Curr. Med. Chem. Anticancer Agents 4(3), 301-316 (2004).
74. R. Hornung, M. J. Hammer-Wilson, S. Kimel, L. H. Liaw, Y. Tadir, and M. W. Berns, "Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: Photodynamic response of CAM vessels and 5-Aminolevulinic acid uptake kinetics by transplantable tumors," J. Photochem. Photobiol. B 49(1), 41-49 (1999).
75. D. M. Strick, R. L. Waycaster, J. P. Montani, W. J. Gay, and T. H. Adair, "Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia," Am. J. Physiol. 260, H1385-H1389 (1991).
76. N. Lange, J.-P. Ballini, G. Wagnieres, and H. van den Bergh, "A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV," Invest. Ophthalmol. Vis. Sci. 42(1), 38-46 (2001).